AMY PARRALES: Open Payments
NPI 1457117350 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 83 payments from 20 companies in 2025. Trend: 2023 $129 · 2024 $724 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $174 |
| Novo Nordisk Inc | 10 | $174 |
| ABBVIE INC. | 13 | $164 |
| Lilly USA, LLC | 8 | $142 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Dexcom, Inc. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $54 |
| Exact Sciences Corporation | 3 | $49 |
Products named: JARDIANCE, TRELEGY ELLIPTA, VRAYLAR, NURTEC ODT, Dexcom G6 Transmitter, QULIPTA, Veozah, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
